Top

World Journal of Surgery

Published in:

01-10-2011

Ten Years After Arterial Bypass Surgery for Claudication: Venous Bypass is the Primary Procedure for TASC C and D Lesions

Authors: Thomas Eugster, Regula Marti, Lorenz Gurke, Peter Stierli

Published in: World Journal of Surgery | Issue 10/2011

Abstract

Background

The appropriate role for surgery and endovascular therapy for severe intermittent claudication (IC) remains controversial. We present our results after infrainguinal autogenous bypass for severe IC more than 10 years ago giving a reasoned argument to perform vein bypass as the primary procedure for severe IC.

Methods

Our prospectively designed database includes more than 1,000 infrainguinal bypasses following an all-autogenous policy. For this review only patients operated on for severe IC at least 10 years ago were included. The primary end points were survival and primary and assisted-primary patency rates.

Results

From October 1988 until December 2000, 124 bypasses for IC were performed. Ninety-five patients were male and the mean age was 64.5 ± 10.8 years. Survival after 10 years was 50.3% according to life table analysis. Forty bypasses were to the supragenicular artery, 62 to the infragenicular popliteal artery, and 22 to the tibial artery. Thirty-day mortality was 0.8% (1 patient). The primary patency rate after 10 years was 63.5% and the assisted-primary patency rate 87.3%.

Conclusion

Infrainguinal venous bypass for severe IC has excellent long-term results. Our results are strong arguments against the liberal use of stenting long lesions of the femoropopliteal artery. Venous bypass remains the primary procedure for TASC C and D lesions in claudicants.

Dormandy J, Rutherford R (2000) Management of peripheral artery disease (PAD): Trans Atlantic Inter-Society Consensus (TASC). J Vasc Surg 31:S1–S296PubMedCrossRef

Norgren L, Hiat WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, on behalf of the TASC II Working Group (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33:S1–S75PubMedCrossRef

Nolan B, Finlayson S, Tosteson A, Powell R, Cronenwett J (2007) The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease–decision analysis. J Vasc Surg 45:1179–1184PubMedCrossRef

Dearing DD, Patel KR, Compoginis JM, Kamel MA, Weaver FA, Katz SG (2009) Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg 50:542–547PubMedCrossRef

Menard MT, Belkin M (2007) Infrapopliteal intervention for the treatment of the claudicant. Semin Vasc Surg 20:42–53PubMedCrossRef

Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML (2008) Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease. J Vasc Surg 48:1166–1174PubMedCrossRef

Eugster T, Gurke L, Obeid T, Stierli P (2002) Infrainguinal arterial reconstruction: female gender as risk factor for outcome. Eur J Vasc Endovasc Surg 24:245–248PubMedCrossRef

ACC/AHA Task Force Report (1996) Special report: guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Cardiothorac Vasc Anaesth 10:540–552

Rutherford RB, Baker D, Ernst C, Johnston KW, Porter JM, Ahn S et al (1997) Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26:517–538PubMedCrossRef

10.

Cheng SWK, Ting AWC, Ho P (2003) Angioplasty and primary stenting of high-grade, long segment superficial femoral artery disease: Is it worthwhile? Ann Vasc Surg 17:430–437PubMedCrossRef

11.

Sabeti S, Mlekusch W, Amighi j, Minar E, Schillinger M (2005) Primary patency of long-segment self-expanding nitinol stents in the femoro-popliteal arteries. J Endovasc Ther 12:6–12PubMedCrossRef

12.

Ihnat DM, Duong ST, Taylor ZC, Leon LR, Mills JL, Goshima KR et al (2008) Contemporary outcome after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score. J Vasc Surg 47:967–974PubMedCrossRef

13.

Shah PS, Hingorani A, Ascher E, Shiferson A, Gopal K, Jung D et al (2011) Full metal jacket stenting of the superficial femoral artery: a retrospective review. Ann Vasc Surg 25:127–131PubMedCrossRef

14.

Laird JR, Katzen BT, Scheiner D, Lammer J, Carpenter J, Buchbinder M et al (2010) Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 3:267–276PubMedCrossRef

15.

Ferreira M, Lanziotti L, Monteiro M, Abuhadba G, Capotorto LF et al (2007) Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg 34:702–708PubMedCrossRef

16.

Krankenberg H, Sorge I, Zeller T, Tübler T (2005) Percutaneous transluminal angioplasty of infrapopliteal arteries in patients with intermittent claudication: acute and one-year results. Catheter Cardiovasc Interv 64:12–17PubMedCrossRef

17.

Laird JR (2006) Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 13(Suppl 2):II30–II40PubMed

18.

Scheinert D, Scheinert S, Sax J, Piorkowski C, Bräunlich S, Ulrich M et al (2005) Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45:312–315PubMedCrossRef

19.

Gur I, Lee W, Akopian G, Rowe VL, Weaver FA et al (2001) Clinical outcomes and implications of failed infrainguinal endovascular stents. J Vasc Surg 53:658–666CrossRef

20.

Conte MS, Belkin M, Donaldson MC, Baum P, Mannick JA, Whittemore AD (1995) Femorotibial bypass for claudication: do results justify an aggressive approach? J Vasc Surg 21:873–880PubMedCrossRef

21.

Byrne J, Darling RC, Chang BB, Paty PS, Kreienberg PB et al (1999) Vascular Surgical Society of Great Britain and Ireland: review of 94 tibial bypasses for intermittent claudication. Br J Surg 86:706–707PubMedCrossRef

22.

Curi MA, Skelly Cl, Woo DH, Desai TR, Katz D, McKinsey JF et al (2002) Long-term results of infrageniculate bypass grafting using all-autogenous composite vein. Ann Vasc Surg 16:618–623PubMedCrossRef

Title: Ten Years After Arterial Bypass Surgery for Claudication: Venous Bypass is the Primary Procedure for TASC C and D Lesions
Authors: Thomas Eugster
Regula Marti
Lorenz Gurke
Peter Stierli
Publication date: 01-10-2011
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 10/2011
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-011-1237-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ten Years After Arterial Bypass Surgery for Claudication: Venous Bypass is the Primary Procedure for TASC C and D Lesions

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 10/2011

“Consideration not Promotion”: In Selected Cases, We Can Try to Increase Donor Body Weight to Increase Graft Volume in Living Donor Liver Transplantation: Reply

External Validation of Two Nomograms for Predicting Patient Survival After Hepatic Resection for Metastatic Colorectal Cancer

Tertiary Survey Performance in a Regional Trauma Hospital Without a Dedicated Trauma Service

Increasing the Size Limit of Benign Thyroid Lesions Resectable by Endoscopic Thyroidectomy via a Unilateral Axillo-breast Approach Without Gas Insufflation

The Extended Indication of Parotidectomy Using the Modified Facelift Incision in Benign Lesions: Retrospective Analysis of a Single Institution

Pancreatic Cancer, Healthcare Cost, and Loss of Productivity: A Register-based Approach